Details for New Drug Application (NDA): 050591
✉ Email this page to a colleague
NDA 050591 describes BACTROBAN, which is a drug marketed by Glaxosmithkline and is included in three NDAs. Additional details are available on the BACTROBAN profile page.
The generic ingredient in BACTROBAN is mupirocin. There are sixteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
The generic ingredient in BACTROBAN is mupirocin. There are sixteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
Summary for 050591
| Tradename: | BACTROBAN |
| Applicant: | Glaxosmithkline |
| Ingredient: | mupirocin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050591
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 31, 1987 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
